Also listed under Neurocognitive Disorders
Dementia clinical trials
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-22
What changed in the last 30 days
134 trials changed in the last 30 days: 5 stopped, 55 with notable changes, 74 with minor changes only.
- Stopped: CarES · Penn State Emergency Medicine CarES: Care-partner Evaluation and Sourcing in the Emergency Department Withdrawn before enrolling
- Notable: SHR 3201 Injection in Healthy Participants Recruitment opened
- Notable: STAND · Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia Results posted: Nov 20, 2026
- Minor: GERAS-US · Health Care Use and Costs · Early Stage Alzheimer's Disease (AD) Trial completed
- Minor: MAINSTREAM · Multimodal Approach for Clinical Diagnosis and Treatment of Primary Progressive Aphasia, MAINSTREAM ID:3430931 Trial status changed: Unknown → Completed
- Minor: DemReg · German Dementia Registry Trial sites expanded: 24 → 29 locations
- Stopped: VNS · Vagus Nerve Stimulation to Enhance Memory in Aging Withdrawn before enrolling
- Notable: Benefits of Personalised Music in Dementia - a Feasibility Study Primary and study completion pushed from Apr 30, 2026 to Nov 30, 2027
- Notable: Self-Control Module of a Positive Mental Health Promotion Programme for Adult Informal Caregivers · Dementia: Protocol for a Randomised Controlled Trial Enrollment reopened
- Notable: Personalized Optimal Gamma Auditory Frequency Stimulation Intervention on Cognitive Function Enhancement Recruitment opened
- Notable: Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin Eligibility criteria changed
- Notable: BHPRO-IMP · Implementing Brain Health PRO Across Diverse Settings: A Multi-Site Implementation Study Eligibility criteria changed
- Minor: PAS-MCI · Acoustic Stimulation During Sleep: Effects on Memory and p-tau217 in MCI Primary completion pushed from Sep 2027 to Dec 2027
- Minor: DIAN-TU · Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments · a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation Trial sites reduced: 36 → 31 locations
- Minor: DUET-AD · Dual Study Assessing Safety and Efficacy of Buntanetap · Early AD Final enrollment: 861 participants (planned 760)
- Minor: LIPUS-Brain · Early Alzheimer's Disease Study completion pushed from Jul 31, 2026 to Mar 31, 2027
- Notable: CORDIAL · Attenuation of Postprandial Inflammatory Processes in Alzheimer's Disease Patients by Consumption of Pomace Oil Primary completion pushed from May 30, 2026 to Dec 30, 2026
- Notable: SVAT · Differencens in VO2-max, Perfusion of the Heart and Brain and Cognitive Performance Between · Type 2 Diabetes and Healthy Age Matched Controls Primary completion pushed from Jan 2027 to Dec 2, 2027
- Notable: LY4560736 in Healthy Participants and · Alzheimer's Disease (AD) Recruitment opened
- Notable: TOBY ATLAS · Urine Volatile Organic Compounds for Disease Detection Eligibility criteria changed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New sponsor entrants, last 90 days sponsors with their first trial in this area
| First posted | Trial | Sponsor | Phase |
|---|---|---|---|
| 2026-11-19 | NCT07947953 A Prospective, Randomized, Placebo-Controlled Double Blind, 18 Month Study Evaluating the… | Koser, Robert B., MD PA new | |
| 2026-11-17 | NCT07943702 Correlation Between Visual Reading and DOlab Software Quantitative Analysis of DaT-SPECT… | Dorian Technologies S.r.l. new | |
| 2026-11-12 | NCT07930364 Wearable HRV Biofeedback for Stress in Dementia Caregivers | Instituto de Investigación Marqués de Valdecilla new | |
| 2026-11-12 | NCT07933042 A Study of Urine Volatile Organic Compounds for Disease Detection | Toby, Inc. new | |
| 2026-11-09 | NCT07926438 40 Hz Audio-Visual Stimulation Therapy for AD | The First Affiliated Hospital of Xiamen University new | |
| 2026-11-05 | NCT07918638 Prospective Research on Identification of Dementia in Early Stages (P.R.I.D.E) | Don Mottola Medical Center new | |
| 2026-11-03 | NCT07912710 China HEalthy Aging and Dementia Study (HEAD) | Fudan University new | |
| 2026-10-30 | NCT07907042 Effects of Doll Therapy on Apathy and Activities of Daily Living Initiation Deficits in… | Xinyu ZHANG new | |
| 2026-10-30 | NCT07905872 Feasibility of Community Occupational Therapy for Dementia (COT-D) | University of Vic - Central University of Catalonia new | |
| 2026-10-29 | NCT07905352 A Phase 2 Clinical Study of Simenafil Hydrochloride Tablets in the Treatment of… | Vigonvita Life Sciences new | Phase 2 |
Active trials by phase
| Early Phase 1 | 21 | |
| Phase 1 | 76 | |
| Phase 1/2 | 50 | |
| Phase 2 | 138 | |
| Phase 2/3 | 18 | |
| Phase 3 | 70 | |
| Phase 4 | 32 |
Not charted: 1,112 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Top sponsors by active trials in this area
Xuanwu Hospital, Beijing (25) · Mayo Clinic (19) · Washington University School of Medicine (19) · Eli Lilly and Company (18) · Johns Hopkins University (17) · Massachusetts General Hospital (16) · Assistance Publique - Hôpitaux de Paris (14) · Chang Gung Memorial Hospital (12) · Indiana University (12) · The University of Hong Kong (12)
Get alerts when Dementia trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.